title: Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48.
abstract: Fracture healing presents a sequence of three major stages: inflammation and granulation tissue formation, callus formation and remodeling. Our working hypothesis was that fracture-repair might be enhanced by stimulating proliferation of chondrocytes and osteoblasts in the early stages of fracture healing followed by sequential acceleration of the remodeling process. In the present study we employed a novel device developed by us implementing a standardized fracture in rat tibiae. We investigated the effect of PTH 28-48 or PTH 1-34 alone or in sequence combination with IL-6 together with its soluble receptor (IL-6sR) on fracture repair. PTH 28-48 or PTH 1-34 was applied locally into the hematoma of fractures on days 4, 5 and 6 and IL-6+ its soluble receptor on days 7, 9, and 11. Post-fracture callus volume as measured 14 days post-fracture was increased significantly only by PTH 1-34 (20%; P<0.01). When one of the PTH fragments and IL-6+IL-6sR were applied sequentially callus volume was increased significantly (33%; P<0.01). X-rays radiography at 5 weeks post-fracture showed enlarged callus volume following treatment by either PTH fragments alone, and complete union following the sequential injection of both PTH fragments and IL-6+IL-6sR, only. Only the combination of one of the PTH fragments with IL-6+IL-6sR, as measured 6 weeks post-fracture by three point bending, changed dramatically the quality of the regenerating bone as presented by a 300% increase in mechanical resistance when PTH 1-34 was combined and 200% when PTH 28-48 was combined relative to vehicle-treated fractured bones. We conclude that the sequential application of IL-6+IL-6sR with both PTH fragments has the potential of enhancing fracture healing in long bones and should be further explored in preclinical and in clinical studies.
authors.affiliation: Department of Anatomy and Cell Biology, The Rappaport Family Faculty of Medicine, Technion-Israel Institute of Technology, PO Box 9649, Haifa 31096, Israel.
authors.forename: Nimrod
authors.initials: N
authors.lastname: Rozen
authors.forename: Dina
authors.initials: D
authors.lastname: Lewinson
authors.forename: Tova
authors.initials: T
authors.lastname: Bick
authors.forename: Zvi C
authors.initials: ZC
authors.lastname: Jacob
authors.forename: Haim
authors.initials: H
authors.lastname: Stein
authors.forename: Michael
authors.initials: M
authors.lastname: Soudry
mesh_terms: D000818:Animals; D001696:Biomechanical Phenomena; D002146:Bony Callus / Q000187:drug effects* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D017102:Fracture Healing / Q000187:drug effects*; D015850:Interleukin-6 / Q000008:administration & dosage*; D010281:Parathyroid Hormone / Q000008:administration & dosage*; D010446:Peptide Fragments / Q000008:administration & dosage*; D051381:Rats; D017208:Rats, Wistar; D019947:Receptors, Interleukin-6 / Q000008:administration & dosage; D013978:Tibial Fractures / Q000188:drug therapy* / Q000473:pathology
chemical_list: D015850:Interleukin-6; D010281:Parathyroid Hormone; D010446:Peptide Fragments; D019947:Receptors, Interleukin-6